In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events…
Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer immunotherapy portfolio.
Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to dazzle. But shares traded higher in the premarket session.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014. They include Chevron, Gap, Merck, Microsoft and Zynga.
The 30 stocks comprising the Dow Jones Industrial Average combined to post a loss of just over 4.5% in January. Only four of the blue chip stocks managed to post a gain…
thinkstockJanuary 27, 2014: Markets opened slightly higher on Monday and equities spent the day bouncing around the breakeven line. Tech stocks trailed behind, never quite rising above breakeven after the opening bell.…
The stock market was pounded on Friday, making for a very bad week and a rough start for January. Still, not all is lost. A few stocks managed to avoid the carnage.…
ThinkstockWednesday was yet another mixed day in the stock market, one where the Dow Jones Industrial Average was in the red and the S&P 500 Index and NASDAQ were positive for most…
Jon OggThe markets had only a small employment report from the Conference Board to consider on Monday, as well as a surprising government budget surplus, to drive stocks today. Unfortunately, Goldman Sachs…
Jon OggWe are now well past the end of 2013, and many strategists have mixed targets for the stock and bond markets in 2014. The last year brought gains of 26.5% in…
With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer and rival Merck & Co.
courtesy of VerizonThe short interest data for the end of November is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. Some of the…
ThinkstockThere is a trend at the end of each year followed by many income investors. This is the Dogs of the Dow, which is simply made up of the 10 Dow Jones…
ThinkstockInvestors love dividends, particularly safe and dependable dividends that rise through time. The S&P 500 Index currently has the most companies paying dividends in nearly two decades. The year 2013 has seen…
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies locally, but a new report from IMS Health shows that the total…
